Clinical evaluation of the BD ProbeTec ™ Neisseria gonorrhoeae Q x Amplified DNA Assay on the BD Viper ™ System with XTR™ Technology

Sexually Transmitted Diseases

Volumn 39, Issue 2, 2012, Pages 147-153

  Van Der Pol, Barbara ^a,b   Taylor, Stephanie N ^c   Lebar, William ^d   Davis, Thomas ^e   Fuller, Deanna ^e   Mena, Leandro ^f   Fine, Paul ^g   Gaydos, Charlotte A ^h   Martin, David H ^c   Hook, Edward W ^i,j  

^a INDIANA UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e WISHARD HEALTH SERVICES   (United States)

^f Planned Parenthood Houston   (United States)

^g UNIVERSITY OF MISSISSIPPI   (United States)

^h JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^j Jefferson County Department of Health   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BACTERIUM IDENTIFICATION; DIAGNOSTIC ACCURACY; DNA DETERMINATION; EVALUATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEISSERIA GONORRHOEAE; NONHUMAN; NUCLEIC ACID AMPLIFICATION; SCREENING; SENSITIVITY AND SPECIFICITY; SEXUALLY TRANSMITTED DISEASE; SMEAR; URETHRA SWAB; URINALYSIS; UTERINE CERVIX CYTOLOGY; VAGINA SMEAR;

ADOLESCENT; ADULT; DNA, BACTERIAL; FEMALE; GONORRHEA; HUMANS; MALE; MIDDLE AGED; NEISSERIA GONORRHOEAE; NUCLEIC ACID AMPLIFICATION TECHNIQUES; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; URINE; VAGINA; YOUNG ADULT;

EID: 84855829543     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e3182372fd8     Document Type: Article

References (17)

1. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2009. Atlanta, GA: U.S. Department of Health and Human Services; 2010.
2. Shafer MA, Moncada J, Boyer CB, et al. Comparing first-void urine specimens, self-collected vaginal swabs, and endocervical specimens to detect Chlamydia trachomatis and Neisseria gonorrhoeae by a nucleic acid amplification test. J Clin Microbiol 2003; 41:4395-4399. (Pubitemid 37099713)
3. Hsieh YH, Howell MR, Gaydos JC, et al. Preference among female Army recruits for use of self-administered vaginal swabs or urine to screen for Chlamydia trachomatis genital infections. Sex Transm Dis 2003; 30:769-773. (Pubitemid 37229487)
4. Schachter J, McCormack WM, Chernesky MA, et al. Vaginal swabs are appropriate specimens for diagnosis of genital tract infection with Chlamydia trachomatis. J Clin Microbiol 2003; 41:3784-3789. (Pubitemid 36994716)
5. Chernesky MA, Hook EW, Martin DH, et al. Women find it easy and prefer to collect their own swabs to diagnose Chlamydia trachomatis and Neisseria gonorrhoeae infectitons. Sex Transm Dis 2005; 32:729-733. (Pubitemid 41752558)
6. Gaydos CA, Crotchfelt KA, Shah N, et al. Evaluation of dry and wet transported intravaginal swabs in detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections in female soldiers by PCR. J Clin Microbiol 2002; 40:758-761. (Pubitemid 34208619)
7. Rompalo AM, Gaydos CA, Shah N, et al. Evaluation of use of a single intravaginal swab to detect multiple sexually transmitted diseases in active-duty military women. Clin Infect Dis 2001; 33:1455-1461. (Pubitemid 34246136)
8. Knox J, Tabrizi SN, Miller P, et al. Evaluation of self-collected samples in contrast to practitioner-collected samples for detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis by polymerase chain reaction among women living in remote areas Sex Transm Dis 2002; 29:647-654. (Pubitemid 35266406)
9. Polaneczky M, Quigley C, Pollock L, et al. Use of self-collected vaginal specimens for detection of Chlamydia trachomatis infection. Obstet Gynecol 1998; 91:375-378. (Pubitemid 28119838)
10. Chernesky MA, Martin DH, Hook EW III, et al. Ability of new APTIMA CT and APTIMA GC assays to detect Chlamydia trachomatis and Neisseria gonorrhoeae in male urine and urethral swabs. J Clin Microbiol 2005; 43:127-131. (Pubitemid 40096289)
11. Gaydos CA, Quinn TC, Willis D, et al. Performance of the APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens. J Clin Microbiol 2003; 41:304-309. (Pubitemid 36098592)
12. Van Der Pol B, Ferrero DV, Buck-Barrington K, et al. Multicenter evaluation of the BD ProbeTec ET system for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine specimens, female endocervical swabs, and male urethral swabs. J Clin Microbiol 2001; 39:1008-1016. (Pubitemid 32215284)
13. Taylor SN, Van Der Pol B, Lillis R, et al. Clinical Evaluation of the BD ProbeTec™ Chlamydia trachomatis Qx Amplified DNA Assay on the BD Viper™ System With XTR™ Technology. Sex Transm Dis 2011; 38:603-609.
14. Felder RA, Foster M, Lizzi M, et al. Process evaluation of a fully automated molecular diagnostics system. JALA 2009; 14:262-268.
15. Moncada J, Chow JM, Schachter J. Volume effect on sensitivity of nucleic acid amplification tests for detection of Chlamydia trachomatis in urine specimens from females. J Clin Microbiol 2003; 41:4842-4843. (Pubitemid 37259812)
16. Martin DH, Nsuami M, Schachter J, et al. Use of multiple nucleic acid amplification tests to define the infected-patient "gold standard" in clinical trials of new diagnostic test for Chlamydia trachomatis infections. J Clin Microbiol 2004; 42: 4749-4758. (Pubitemid 39362398)
17. Centers for Disease Control and Prevention. Laboratory diagnostic testing for Chlamydia trachomatis and Neisseria gonorrhoeae. Am Public Health Laboratories; 2009 [updated 2009; cited 19 July 2010]. Available from: http://www.aphl.org/aphlprograms/infectious/std/documents/ ctgclabguidelinesmeetingreport.pdf.